| 88886-7 |
Telavancin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Telavancin [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88886-7 |
|
|
|
|
Both |
|
|
|
0 |
Telavancin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vibativ |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88887-5 |
Isavuconazole |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Isavuconazole [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88887-5 |
|
|
|
|
Both |
|
|
|
0 |
Isavuconazole Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Triazole |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88888-3 |
Pancreatic stone protein |
MCnc |
Ser/Plas/Bld |
Pt |
Qn |
IA.rapid |
|
ACTIVE |
Pancreatic stone protein [Mass/volume] in Serum, Plasma or Blood by Rapid immunoassay |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHEM |
|
88888-3 |
|
IA.rapid |
|
|
Both |
|
|
|
0 |
PSP SerPlBld IA.rapid-mCnc |
|
|
|
|
|
Blood; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Lithostathine-1-alpha; Mass concentration; MEIA; Pancr; Pancreatc; Pl; PlasBld; Plasma; Plsm; Point in time; PR; Prot; PSP; QNT; Quan; Quant; Quantitative; Random; REG-a1; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood |
2.64 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88889-1 |
Middle east respiratory syndrome coronavirus RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Middle East respiratory syndrome coronavirus (MERS-CoV) RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88889-1 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
MERS-CoV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 8889-8 |
Heart rate |
NRat |
Capillary bed |
Pt |
Qn |
Pulse oximetry |
|
ACTIVE |
Heart rate by Pulse oximetry |
|
MIN |
DefinitionDescription |
|
|
beats/min |
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8889-8 |
|
Pulse oximetry |
|
|
|
|
|
|
0 |
Heart rate PulseOx |
|
|
|
|
|
Cardio; Cardiology; Count/time; Heart beat; Heart Disease; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; Point in time; Pulse; PulseOx; QNT; Quan; Quant; Quantitative; Random; SpO2 |
2.7 |
1.0h(3) |
|
|
|
|
|
|
|
{beats}/min |
|
|
Changed the Method from "oximetry" to the more accurate "pulse oximetry" |
0 |
| 88890-9 |
Parainfluenza virus 1+2+3+4 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 1+2+3+4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88890-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV 1+2+3+4 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV 1+2+3+4; HPIV 1+2+3+4 RNA; HPIV1; HPIV1+2+3; Human respirovirus 1; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88891-7 |
Human coronavirus 229E+HKU1+NL63+OC43 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human coronavirus 229E+HKU1+NL63+OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88891-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HCoV 229E+HKU1+NL63+OC43 Np Ql NAA+nonpr |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; CoV 229E+HKU1+NL63+OC43; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; HCoV 229E+HKU1+NL63+OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.66 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Updated order of analytes in Component from Human coronavirus 229E+HKU1+OC43+NL63 RNA for consistency across terms. |
0 |
| 88892-5 |
Meropenem+Vaborbactam |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Meropenem+Vaborbactam [Susceptibility] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
88892-5 |
|
|
|
|
Both |
|
|
|
0 |
Mero+Vab Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klebsiella pneumonia carbapenemase; KPC; Mero+Vab; Meronem; Merrem; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vabomere |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88893-3 |
Coagulation tissue factor induced.PIVKA sensitive |
Time |
PPP |
Pt |
Qn |
|
|
ACTIVE |
Prothrombin time (PT) PIVKA sensitive in Platelet poor plasma |
|
ADD |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
88893-3 |
|
|
|
|
Both |
|
|
|
0 |
PT PIVKA sensitive PPP |
|
|
|
|
|
Coag; Fac; Fact; Hematology; Heme; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT PIVKA sensitive; QNT; Quan; Quant; Quantitative; Random |
2.64 |
2.64 |
|
|
|
|
|
|
|
s |
|
|
|
0 |
| 88894-1 |
Brivaracetam |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Brivaracetam [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88894-1 |
|
|
|
|
Both |
|
|
|
0 |
Brivaracetam SerPl-mCnc |
|
|
|
|
|
Anticonvulsant; Antiseizure; Briviact; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88895-8 |
Perampanel |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Perampanel [Mass/volume] - Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88895-8 |
|
|
|
|
Both |
|
|
|
0 |
Perampanel SerPl-mCnc |
|
|
|
|
|
Anticonvulsant; Antiseizure; DRUG/TOXICOLOGY; Drugs; Fycompa; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.65 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88896-6 |
Reboxetine |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Reboxetine [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
88896-6 |
|
|
|
|
Both |
|
|
|
0 |
Reboxetine SerPl-mCnc |
|
|
|
|
|
Davedax; DRUG/TOXICOLOGY; Drugs; Edronax; Level; Mass concentration; Norebox; Pl; Plasma; Plsm; Point in time; Prolift; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solvex; SR; Vestra |
2.64 |
2.64 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 88897-4 |
Adenovirus Ag |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
IF |
|
ACTIVE |
Adenovirus Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88897-4 |
|
IF |
|
|
Both |
|
|
|
0 |
HAdV Ag Lower resp Ql IF |
|
|
|
|
|
ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; Breathing; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Time Resolved Fluorescence; TRF |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88898-2 |
Adenovirus |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Adenovirus [Presence] in Lower respiratory specimen by Organism specific culture |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88898-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HAdV Lower resp Ql Cult |
|
|
|
|
|
Adeno virus; Breathing; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88899-0 |
Adenovirus |
PrThr |
Cornea/Conjunctiva |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Adenovirus [Presence] in Cornea or Conjunctiva by Organism specific culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88899-0 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HAdV Corn/Cnjt Ql Cult |
|
|
|
|
|
Adeno virus; C&S; Corn/Cnjt; Corneal; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 889-6 |
Blood group antibodies |
Prid |
^BPU |
Pt |
Nom |
|
|
ACTIVE |
Blood group antibodies identified in Blood product unit |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
889-6 |
|
|
|
|
Both |
|
|
|
0 |
Blood group antibodies BPU |
|
|
|
|
|
BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Identity or presence; Nominal; Point in time; Random |
2.79 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 8890-6 |
Heart rate |
NRat |
Cardiac apex |
Pt |
Qn |
Auscultation |
|
ACTIVE |
Heart rate Cardiac apex by Auscultation |
|
MIN |
DefinitionDescription |
|
|
beats/min |
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8890-6 |
|
Auscultation |
|
|
|
|
|
|
0 |
Heart rate Cardiac Apex Auscultation |
|
|
|
|
|
Ausc; Count/time; Heart beat; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0h(3) |
|
|
|
|
|
|
|
{beats}/min |
|
|
|
0 |
| 88900-6 |
Adenovirus |
PrThr |
Respiratory system specimen.upper |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Adenovirus [Presence] in Upper respiratory specimen by Organism specific culture |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88900-6 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HAdV Upper resp Ql Cult |
|
|
|
|
|
Adeno virus; Breathing; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Lung; Lungs; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Up; Upper resp |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88901-4 |
Adenovirus |
PrThr |
Stool |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Adenovirus [Presence] in Stool by Organism specific culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88901-4 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HAdV Stl Ql Cult |
|
|
|
|
|
Adeno virus; Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Stl; Stool = Fecal |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88902-2 |
Adenovirus |
PrThr |
Urine |
Pt |
Ord |
Organism specific culture |
|
ACTIVE |
Adenovirus [Presence] in Urine by Organism specific culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88902-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HAdV Ur Ql Cult |
|
|
|
|
|
Adeno virus; C&S; Cult; Cultures; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; UA; UR; Urn |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88903-0 |
Influenza virus B Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Influenza virus B IgG Ab [Presence] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88903-0 |
|
IA |
|
|
Both |
|
|
|
0 |
FLUBV IgG Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS |
2.64 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 88904-8 |
Influenza virus A Ag |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus A Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88904-8 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUAV Ag Lower resp Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; Breathing; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Time Resolved Fluorescence; TRF |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88905-5 |
Influenza virus B Ag |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
IF |
|
ACTIVE |
Influenza virus B Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88905-5 |
|
IF |
|
|
Both |
|
|
|
0 |
FLUBV Ag Lower resp Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Breathing; DFA; FA; FLUB; FLUBV; Fluorescent antibody; Fluoresent; FLUV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Time Resolved Fluorescence; TRF |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88906-3 |
Parainfluenza virus 1 Ag |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
IF |
|
ACTIVE |
Parainfluenza virus 1 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88906-3 |
|
IF |
|
|
Both |
|
|
|
0 |
HPIV1 Ag Lower resp Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Breathing; DFA; FA; Fluorescent antibody; Fluoresent; HPIV; HPIV1; Human respirovirus 1; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Time Resolved Fluorescence; TRF |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
| 88907-1 |
Parainfluenza virus 2 Ag |
PrThr |
Respiratory system specimen.lower |
Pt |
Ord |
IF |
|
ACTIVE |
Parainfluenza virus 2 Ag [Presence] in Lower respiratory specimen by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
88907-1 |
|
IF |
|
|
Both |
|
|
|
0 |
HPIV2 Ag Lower resp Ql IF |
|
|
|
|
|
ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Breathing; DFA; FA; Fluorescent antibody; Fluoresent; HPIV; HPIV2; Human rubulavirus 2; ID; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Lungs; Microbiology; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PI2; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; RS; Screen; Spec; Time Resolved Fluorescence; TRF |
2.77 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.77: SYSTEM: Updated to standardize the representation of "Respiratory system specimen" in the System subhierarchy across LOINC; |
0 |
